Vimarsana
Biggest News Aggregation in the World

Page 4 - Daniel Teper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Teper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Teper Today - Breaking & Trending Today

Cytovia Therapeutics Mourns the Passing of Cancer Immunotherapy Industry Leader and COO Dr. Olivier Jean-Marie Gouédard - Vimarsana News

Cytovia Therapeutics Mourns the Passing of Cancer Immunotherapy Industry Leader and COO Dr. Olivier Jean-Marie Gouédard

/PRNewswire/ -- Cytovia Therapeutics, Inc. today released the following statement on the passing of Olivier Gouédard, PharmD, MBA, who served as its Chief...

Fintechs flag Australian recruitment problems: KPMG - Vimarsana News

Fintechs flag Australian recruitment problems: KPMG

The number of fintech firms has more than doubled between 2017 and 2021, according to KPMG, but firms are being stymied by recruitment difficulties in the local market.

New challenges and opportunities emerge for Aussie fintechs - Vimarsana News

New challenges and opportunities emerge for Aussie fintechs

KPMG has shared its evaluation of the local fintech industry. The shifting market environment may threaten the efforts of Australia’s growing fintech sector to raise capital and recruit talent thro

Source: ifa.com.au
Cytovia Therapeutics Reports Preclinical Activity of its iPSC-derived NK (iNK) Cells and Flex-NK™ Cell Engagers at the 2022 AACR Annual Meeting - Vimarsana News

Cytovia Therapeutics Reports Preclinical Activity of its iPSC-derived NK (iNK) Cells and Flex-NK™ Cell Engagers at the 2022 AACR Annual Meeting

/PRNewswire/ -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and...

Cytovia Therapeutics Files New Patents for its Natural - Vimarsana News

Cytovia Therapeutics Files New Patents for its Natural

Cytovia Therapeutics Files New Patents for its Natural Killer Cell Engager Multifunctional Antibodies (FLEX-NK®) for the Treatment of Hematological and Solid Tumors First-in-class NK Engager multifunctional antibody products can activate patients’ own NK cells or be combined with Cytovia’s off-the-shelf Universal iPSC-derived NK Cells April 12, 2021 11:11 ET | Source: Cytovia Therapeutics Cytovia Therapeutics Miami, Florida, UNITED STATES CAMBRIDGE, Mass. and AVENTURA, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a b...